Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
24-LUN-138-BNT-PMC (BNT116-01): First-in-Human, Open label, Phase I Dose Confirmation Trial Evaluating The Safety, Tolerability, and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-Small Cell Lung Cancer
Hao, Zhonglin
(PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
11/25/24
→
11/25/26
Funding
BioNTech SE:
$2.00
View all
View less